Tirofiban
Drug Details
- Generic Name
- Tirofiban
- Brand Names
- Tirofiban, Tirofiban hydrochloride
- Application Number
- ANDA216379
- Sponsor
- Eugia US LLC
- NDC Codes
- 3
- Dosage Forms
- INJECTION, SOLUTION
- Routes
- INTRAVENOUS
- Active Ingredients
- TIROFIBAN HYDROCHLORIDE
Indications and Usage
1 INDICATIONS AND USAGE Tirofiban hydrochloride injection is indicated to reduce the rate of thrombotic cardiovascular events (combined endpoint of death, myocardial infarction, or refractory ischemia/repeat cardiac procedure) in patients with non-ST elevation acute coronary syndrome (NSTE-ACS) . Tirofiban hydrochloride injection is a platelet aggregation inhibitor indicated to reduce the rate of thrombotic cardiovascular events (combined endpoint of death, myocardial infarction, or refractory ischemia/repeat cardiac procedure) in patients with non-ST elevation acute coronary syndrome (NSTE-ACS).